Class Action Lawsuit Filed Against Atara Biotherapeutics and Certain Officers
A class action lawsuit has been filed against Atara Biotherapeutics (NASDAQ: ATRA) and certain officers, alleging violations of federal securities laws. The lawsuit seeks to recover damages for investors who purchased Atara securities between May 20, 2024, and January 9, 2026. The case is currently in the United States District Court for the Central District of California.
Tickers: $ATRA